Ignite Creation Date:
2025-12-25 @ 4:25 AM
Ignite Modification Date:
2025-12-26 @ 3:29 AM
Study NCT ID:
NCT00937820
Status:
COMPLETED
Last Update Posted:
2011-01-06
First Post:
2009-07-09
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Prevention of Recurrence of Venous Thromboembolism in Patients With a History of Venous Thromboembolism
Sponsor:
Astellas Pharma Inc
Organization:
Study Overview
Official Title:
YM150 Long Term Study - Long-term Study in Patients With a History of Venous Thromboembolism
Status:
COMPLETED
Status Verified Date:
2011-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study objective is to evaluate the efficacy and safety of oral YM150 for 52 weeks in patients with a history of venous thromboembolism.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: